Defective Drugs
12 Core Facts About GlaxoSmithKline’s Zofran And This Litigation
Type 2 Diabetes Drugs Linked to Adverse Effects
Actos: $2.4 Billion Settlement
Johnson & Johnson’s Janssen Pharmaceuticals Receives Mixed Verdict in Second Risperdal Trial
Takeda Ordered to Pay Over $2 Million to Actos Patient
Hip Implant Systems Not Adequately Tested
Blue Shield and Blue Cross File Claim Over Actos
Jury Awards $9 Billion after an Actos Trial
Possible Settlement for NuvaRing Lawsuits
FDA Begins Regulating Apps
Verdict Reached in First Actos Trial
More Trouble for Maker of Diabetes Drug Actos